Hedge Fund - Redmile Group

Amicus Therapeutics Inc. (FOLD) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q4 (2023-12-31) $210,413,875 7.52% 14,828,321 $11.35
2 2023 - Q3 (2023-09-30) $206,046,591 9.8% 16,944,621 $12.90
3 2023 - Q2 (2023-06-30) $245,761,030 9.43% 19,566,961 $11.87
4 2023 - Q1 (2023-03-31) $203,466,688 8.82% 18,346,861 $12.33
5 2022 - Q4 (2022-12-31) $247,249,924 10.11% 20,249,789 $11.26
6 2022 - Q3 (2022-09-30) $226,748,000 8.79% 21,719,191 $11.14
7 2022 - Q2 (2022-06-30) $237,986,000 9.08% 22,158,891 $8.24
8 2022 - Q1 (2022-03-31) $211,459,000 6.6% 22,329,386 $9.38
9 2021 - Q4 (2021-12-31) $262,371,000 5.96% 22,716,086 $11.14
10 2021 - Q3 (2021-09-30) $198,633,000 3.46% 20,799,303 $10.23
11 2021 - Q2 (2021-06-30) $200,505,000 2.96% 20,799,303 $9.76
12 2021 - Q1 (2021-03-31) $208,607,000 2.93% 21,114,114 $15.48
13 2020 - Q4 (2020-12-31) $476,127,000 5.76% 20,620,490 $20.45
14 2020 - Q3 (2020-09-30) $325,830,000 5.98% 23,075,807 $14.57
15 2020 - Q2 (2020-06-30) $376,166,000 6.94% 24,944,695 $12.19
16 2020 - Q1 (2020-03-31) $232,677,000 6.52% 25,181,500 $9.51
17 2019 - Q4 (2019-12-31) $245,545,000 5.87% 25,209,964 $9.15
18 2019 - Q3 (2019-09-30) $182,777,000 6.11% 22,790,134 $10.85
19 2019 - Q2 (2019-06-30) $284,452,000 8.04% 22,792,634 $12.69
20 2019 - Q1 (2019-03-31) $266,778,000 7.8% 19,616,062 $12.22
21 2018 - Q4 (2018-12-31) $79,736,000 3.2% 8,323,217 $10.99
22 2018 - Q3 (2018-09-30) $101,588,000 3.12% 8,402,617 $13.98
23 2018 - Q2 (2018-06-30) $164,193,000 5.57% 10,511,732 $15.12
24 2018 - Q1 (2018-03-31) $161,509,000 6.23% 10,738,658 $15.22
25 2017 - Q4 (2017-12-31) $144,271,000 6.27% 10,025,770 $13.74
26 2017 - Q3 (2017-09-30) $166,069,000 8.19% 11,012,561 $13.23
27 2017 - Q2 (2017-06-30) $121,282,000 7.38% 12,043,932 $8.05
28 2017 - Q1 (2017-03-31) $81,110,000 5.26% 11,375,852 $6.32
29 2016 - Q4 (2016-12-31) $61,286,000 5.28% 12,331,130 $6.92
30 2016 - Q3 (2016-09-30) $94,361,000 7.5% 12,751,536 $6.75
31 2016 - Q2 (2016-06-30) $60,641,000 5.79% 11,106,446 $6.99
32 2016 - Q1 (2016-03-31) $90,571,000 9.26% 10,718,420 $7.08
33 2015 - Q4 (2015-12-31) $99,722,000 7.46% 10,280,620 $9.01
34 2015 - Q3 (2015-09-30) $116,578,000 2.67% 8,332,930 $15.68
35 2015 - Q2 (2015-06-30) $89,110,000 7.3% 6,297,523 $12.02
36 2015 - Q1 (2015-03-31) $63,455,000 5.69% 5,832,228 $8.81
37 2014 - Q4 (2014-12-31) $57,202,000 6.22% 6,875,274 $6.86
38 2014 - Q3 (2014-09-30) $33,956,000 3.92% 5,706,906 $5.24
39 2014 - Q2 (2014-06-30) $25,552,000 3.09% 7,650,268 $2.35
40 2014 - Q1 (2014-03-31) $17,588,000 2.08% 8,496,538 $2.50
41 2013 - Q4 (2013-12-31) $20,323,000 2.5% 8,648,087 $2.20
42 2013 - Q3 (2013-09-30) $5,739,000 0.86% 2,473,787 $2.51
43 2013 - Q2 (2013-06-30) $5,531,000 0.97% 2,373,687 $3.07
44 2013 - Q1 (2013-03-31) $6,313,000 1.15% 1,991,490 $3.38
45 2012 - Q4 (2012-12-31) $3,006,000 0.87% 1,121,700 $5.04

The displayed share prices are average quarterly stock market prices.